NCT07205601View on ClinicalTrials.gov

Study of Intracerebroventricular Injections of Autologous Adipose-Derived Stem Cells (RB-ADSCs) in Participants With Mild-Moderate Alzheimer's Disease

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

March 31, 2028

Study Completion Date

March 31, 2029

Conditions
Alzheimer Disease
Interventions
BIOLOGICAL

RB-ADSC

RB-ADSC is an investigational an ex-vivo expanded autologous adipose-derived stem cell product

OTHER

Placebo

0.9% NaCl USP

All Listed Sponsors
lead

Regeneration Biomedical, Inc.

INDUSTRY

NCT07205601 - Study of Intracerebroventricular Injections of Autologous Adipose-Derived Stem Cells (RB-ADSCs) in Participants With Mild-Moderate Alzheimer's Disease | Biotech Hunter | Biotech Hunter